_id
69109436ccc777a4e85d5a7c
Ticker
EDNSF
Name
Eden Research plc
Exchange
PINK
Address
67C Innovation Drive, Abingdon, United Kingdom, OX14 4RQ
Country
USA
Sector
Basic Materials
Industry
Agricultural Inputs
Currency
USD
Website
https://www.edenresearch.com
Description
Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products comprising companion animal, bio-control, parasite treatments, and insect sprays. Eden Research plc was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.
Last Close
0.054
Volume
20000
Current Price
0.035
Change
0
Last Updated
2026-01-02T13:06:18.934Z
Image
data:image/webp;base64,UklGRkABAABXRUJQVlA4IDQBAACwCQCdASpAAEAAPrVOokunJCMhqhzKMOAWiWUA1H+4SGzGHFMMk/gNjFwGD2IrhXIMfBdYGboKY6KRvPwJfevKrMR8ZSj+IwgltUfJ+oljdD9gYzIwAAD+/7CQH/j/9PZgzyThEYeCDM1tvziUTysuZfNAryC++Wzeo+hSb+tHnuxVOu4r4VQtjPC/+j6XRaUgUq+cVWMBFHMBym3LK8Dd4Lh+cE2izWwAZAxdKiAcoekxFBuva4JghwT2gTa+83ShWKxjmRY3CM04hSkiRW5vo4SnOgDiwcoMQI4uHMU4tf/e2yGL2S0EryHSDtvD7Fa1QQMvVqmM3bGB2af5+Wo6s+lzBYTQOBH8hJS9iCxeCrYHGPku1e0Lixiq5qMGpJKsUu02Bm5cB9Bw4MNMYRyvwgAAAA==
Ipo Date
-
Market Cap
18667338
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
1198535
Cost Of Revenue
1490045
Gross Profit
155303
Operating Expenses
2438602
Operating Income
-2283298
Interest Expense
11122
Pretax Income
-2287038
Net Income
-1866689
Eps
-0.0034999159458368213
Dividends Per Share
-
Shares Outstanding
533352523
Income Tax Expense
-441971
EBITDA
-1587876
Operating Margin
-190.5074111310892
Total Other Income Expense Net
-3740
Cash
1845853
Short Term Investments
-
Receivables
1348747
Inventories
652686
Total Current Assets
5224700
Property Plant Equipment
626064
Total Assets
13464644
Payables
1714752
Short Term Debt
300731
Long Term Debt
-
Total Liabilities
2853055
Equity
10575572
Bs_currency_symbol
GBP
Depreciation
481653
Change In Working Capital
1049074
Cash From Operations
-697413
Capital Expenditures
0
Cash From Investing
-1701836
Cash From Financing
-109597
Net Change In Cash
-2063551
Cf_currency_symbol
-
PE
-
PB
1.7651374606498826
ROE
-17.650950700349824
ROA
-13.863634270612724
FCF
-697413
Fcf Percent
-0.5818878881300922
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1198535
Quarters > 0 > income Statement > cost Of Revenue
1490045
Quarters > 0 > income Statement > gross Profit
155303
Quarters > 0 > income Statement > operating Expenses
2438602
Quarters > 0 > income Statement > operating Income
-2283298
Quarters > 0 > income Statement > interest Expense
11122
Quarters > 0 > income Statement > pretax Income
-2287038
Quarters > 0 > income Statement > net Income
-1866689
Quarters > 0 > income Statement > eps
-0.0034999159458368213
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
533352523
Quarters > 0 > income Statement > income Tax Expense
-441971
Quarters > 0 > income Statement > EBITDA
-1587876
Quarters > 0 > income Statement > operating Margin
-190.5074111310892
Quarters > 0 > income Statement > total Other Income Expense Net
-3740
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1845853
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1348747
Quarters > 0 > balance Sheet > inventories
652686
Quarters > 0 > balance Sheet > total Current Assets
5224700
Quarters > 0 > balance Sheet > property Plant Equipment
626064
Quarters > 0 > balance Sheet > total Assets
13464644
Quarters > 0 > balance Sheet > payables
1714752
Quarters > 0 > balance Sheet > short Term Debt
300731
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2853055
Quarters > 0 > balance Sheet > equity
10575572
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-1359768
Quarters > 0 > cash Flow > depreciation
481653
Quarters > 0 > cash Flow > change In Working Capital
1049074
Quarters > 0 > cash Flow > cash From Operations
-697413
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-1701836
Quarters > 0 > cash Flow > cash From Financing
-109597
Quarters > 0 > cash Flow > net Change In Cash
-2063551
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0034999159458368213
Quarters > 0 > ratios > PB
1.7651374606498826
Quarters > 0 > ratios > ROE
-17.650950700349824
Quarters > 0 > ratios > ROA
-13.863634270612724
Quarters > 0 > ratios > FCF
-697413
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.5818878881300922
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
2416674
Quarters > 1 > income Statement > cost Of Revenue
1138316
Quarters > 1 > income Statement > gross Profit
1278358
Quarters > 1 > income Statement > operating Expenses
2130506
Quarters > 1 > income Statement > operating Income
-852148
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-871488
Quarters > 1 > income Statement > net Income
-990463
Quarters > 1 > income Statement > eps
-0.0018570513071333122
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
533352523
Quarters > 1 > income Statement > income Tax Expense
128770
Quarters > 1 > income Statement > EBITDA
-769558
Quarters > 1 > income Statement > operating Margin
-35.26118955225239
Quarters > 1 > income Statement > total Other Income Expense Net
-19340
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
3674796
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2860868
Quarters > 1 > balance Sheet > inventories
532650
Quarters > 1 > balance Sheet > total Current Assets
7897497
Quarters > 1 > balance Sheet > property Plant Equipment
322301
Quarters > 1 > balance Sheet > total Assets
15405820
Quarters > 1 > balance Sheet > payables
2559056
Quarters > 1 > balance Sheet > short Term Debt
109039
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3568234
Quarters > 1 > balance Sheet > equity
11817319
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-990463
Quarters > 1 > cash Flow > depreciation
331881
Quarters > 1 > cash Flow > change In Working Capital
-556544
Quarters > 1 > cash Flow > cash From Operations
298124
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-1412601
Quarters > 1 > cash Flow > cash From Financing
-71037
Quarters > 1 > cash Flow > net Change In Cash
-4947303
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0018570513071333122
Quarters > 1 > ratios > PB
1.5796593377059553
Quarters > 1 > ratios > ROE
-8.381452679749103
Quarters > 1 > ratios > ROA
-6.4291482050290085
Quarters > 1 > ratios > FCF
298124
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.12336128083473402
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1885929
Quarters > 2 > income Statement > cost Of Revenue
1292117
Quarters > 2 > income Statement > gross Profit
593812
Quarters > 2 > income Statement > operating Expenses
1927943
Quarters > 2 > income Statement > operating Income
-1334131
Quarters > 2 > income Statement > interest Expense
6068
Quarters > 2 > income Statement > pretax Income
-1305309
Quarters > 2 > income Statement > net Income
-916128
Quarters > 2 > income Statement > eps
-0.0017176781968649278
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
533352523
Quarters > 2 > income Statement > income Tax Expense
-395778
Quarters > 2 > income Statement > EBITDA
-1218609
Quarters > 2 > income Statement > operating Margin
-70.74131634860062
Quarters > 2 > income Statement > total Other Income Expense Net
28822
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
4947303
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1609698
Quarters > 2 > balance Sheet > inventories
618190
Quarters > 2 > balance Sheet > total Current Assets
8742229
Quarters > 2 > balance Sheet > property Plant Equipment
376766
Quarters > 2 > balance Sheet > total Assets
15033705
Quarters > 2 > balance Sheet > payables
1720027
Quarters > 2 > balance Sheet > short Term Debt
139773
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2321123
Quarters > 2 > balance Sheet > equity
12682520
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-916128
Quarters > 2 > cash Flow > depreciation
264919
Quarters > 2 > cash Flow > change In Working Capital
332227
Quarters > 2 > cash Flow > cash From Operations
-1306693
Quarters > 2 > cash Flow > capital Expenditures
48649
Quarters > 2 > cash Flow > cash From Investing
-1065625
Quarters > 2 > cash Flow > cash From Financing
-84491
Quarters > 2 > cash Flow > net Change In Cash
4947303
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0017176781968649278
Quarters > 2 > ratios > PB
1.4718950417582628
Quarters > 2 > ratios > ROE
-7.223548632290743
Quarters > 2 > ratios > ROA
-6.093827170348227
Quarters > 2 > ratios > FCF
-1355342
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.7186601404400695
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
2049656
Quarters > 3 > income Statement > cost Of Revenue
716210
Quarters > 3 > income Statement > gross Profit
1333446
Quarters > 3 > income Statement > operating Expenses
2086783
Quarters > 3 > income Statement > operating Income
-664544
Quarters > 3 > income Statement > interest Expense
7668
Quarters > 3 > income Statement > pretax Income
-726974
Quarters > 3 > income Statement > net Income
-607055
Quarters > 3 > income Statement > eps
-0.001317022758946454
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
460929772
Quarters > 3 > income Statement > income Tax Expense
111096
Quarters > 3 > income Statement > EBITDA
-595472
Quarters > 3 > income Statement > operating Margin
-32.422221094661744
Quarters > 3 > income Statement > total Other Income Expense Net
-62430
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
7413107
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2062939
Quarters > 3 > balance Sheet > inventories
964552
Quarters > 3 > balance Sheet > total Current Assets
11144483
Quarters > 3 > balance Sheet > property Plant Equipment
442528
Quarters > 3 > balance Sheet > total Assets
16594719
Quarters > 3 > balance Sheet > payables
1925559
Quarters > 3 > balance Sheet > short Term Debt
142849
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3048922
Quarters > 3 > balance Sheet > equity
13518982
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-607055
Quarters > 3 > cash Flow > depreciation
136739
Quarters > 3 > cash Flow > change In Working Capital
-1832781
Quarters > 3 > cash Flow > cash From Operations
-676695
Quarters > 3 > cash Flow > capital Expenditures
100516
Quarters > 3 > cash Flow > cash From Investing
-1290230
Quarters > 3 > cash Flow > cash From Financing
8967925
Quarters > 3 > cash Flow > net Change In Cash
6920341
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.001317022758946454
Quarters > 3 > ratios > PB
1.1933252089543431
Quarters > 3 > ratios > ROE
-4.490389882906864
Quarters > 3 > ratios > ROA
-3.6581215988050175
Quarters > 3 > ratios > FCF
-777211
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.37919094716381674
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4302603
Annuals > 0 > income Statement > cost Of Revenue
2430433
Annuals > 0 > income Statement > gross Profit
1872170
Annuals > 0 > income Statement > operating Expenses
4058449
Annuals > 0 > income Statement > operating Income
-2186279
Annuals > 0 > income Statement > interest Expense
9732
Annuals > 0 > income Statement > pretax Income
-2180147
Annuals > 0 > income Statement > net Income
-1906591
Annuals > 0 > income Statement > eps
-0.0035747295039982403
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
533352523
Annuals > 0 > income Statement > income Tax Expense
-267008
Annuals > 0 > income Statement > EBITDA
-1587181
Annuals > 0 > income Statement > operating Margin
-50.81293812141162
Annuals > 0 > income Statement > total Other Income Expense Net
6132
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
3674796
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2860868
Annuals > 0 > balance Sheet > inventories
532650
Annuals > 0 > balance Sheet > total Current Assets
7897497
Annuals > 0 > balance Sheet > property Plant Equipment
322301
Annuals > 0 > balance Sheet > total Assets
15405820
Annuals > 0 > balance Sheet > payables
2559056
Annuals > 0 > balance Sheet > short Term Debt
109039
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3568234
Annuals > 0 > balance Sheet > equity
11817319
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-1900044
Annuals > 0 > cash Flow > depreciation
583234
Annuals > 0 > cash Flow > change In Working Capital
343306
Annuals > 0 > cash Flow > cash From Operations
-1008569
Annuals > 0 > cash Flow > capital Expenditures
2588709
Annuals > 0 > cash Flow > cash From Investing
-2478226
Annuals > 0 > cash Flow > cash From Financing
-155528
Annuals > 0 > cash Flow > net Change In Cash
-3738311
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.0035747295039982403
Annuals > 0 > ratios > PB
1.5796593377059553
Annuals > 0 > ratios > ROE
-16.13387097361085
Annuals > 0 > ratios > ROA
-12.375783956972105
Annuals > 0 > ratios > FCF
-3597278
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.8360701649675789
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
3192027
Annuals > 1 > income Statement > cost Of Revenue
1426547
Annuals > 1 > income Statement > gross Profit
1765480
Annuals > 1 > income Statement > operating Expenses
3632171
Annuals > 1 > income Statement > operating Income
-1866691
Annuals > 1 > income Statement > interest Expense
17009
Annuals > 1 > income Statement > pretax Income
-6920262
Annuals > 1 > income Statement > net Income
-6494249
Annuals > 1 > income Statement > eps
-0.01542866025281416
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
420921123
Annuals > 1 > income Statement > income Tax Expense
-428326
Annuals > 1 > income Statement > EBITDA
-6244928
Annuals > 1 > income Statement > operating Margin
-58.4797998262546
Annuals > 1 > income Statement > total Other Income Expense Net
-5053571
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
7413107
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
2062939
Annuals > 1 > balance Sheet > inventories
964552
Annuals > 1 > balance Sheet > total Current Assets
11144483
Annuals > 1 > balance Sheet > property Plant Equipment
442528
Annuals > 1 > balance Sheet > total Assets
16594719
Annuals > 1 > balance Sheet > payables
1925559
Annuals > 1 > balance Sheet > short Term Debt
142849
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3048922
Annuals > 1 > balance Sheet > equity
13518982
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-6491936
Annuals > 1 > cash Flow > depreciation
625077
Annuals > 1 > cash Flow > change In Working Capital
-1125018
Annuals > 1 > cash Flow > cash From Operations
-1695411
Annuals > 1 > cash Flow > capital Expenditures
1752856
Annuals > 1 > cash Flow > cash From Investing
-1718842
Annuals > 1 > cash Flow > cash From Financing
8901690
Annuals > 1 > cash Flow > net Change In Cash
5418635
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.01542866025281416
Annuals > 1 > ratios > PB
1.089744723752129
Annuals > 1 > ratios > ROE
-48.03800315733832
Annuals > 1 > ratios > ROA
-39.13443186353442
Annuals > 1 > ratios > FCF
-3448267
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.0802750102051142
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1827171
Annuals > 2 > income Statement > cost Of Revenue
1620029
Annuals > 2 > income Statement > gross Profit
207142
Annuals > 2 > income Statement > operating Expenses
2774175
Annuals > 2 > income Statement > operating Income
-2567030
Annuals > 2 > income Statement > interest Expense
22046
Annuals > 2 > income Statement > pretax Income
-2536151
Annuals > 2 > income Statement > net Income
-2237262
Annuals > 2 > income Statement > eps
-0.005879031458668529
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
380549418
Annuals > 2 > income Statement > income Tax Expense
-323716
Annuals > 2 > income Statement > EBITDA
-1858109
Annuals > 2 > income Statement > operating Margin
-140.49205027881902
Annuals > 2 > income Statement > total Other Income Expense Net
-562
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
1994472
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
479652
Annuals > 2 > balance Sheet > inventories
625458
Annuals > 2 > balance Sheet > total Current Assets
3602512
Annuals > 2 > balance Sheet > property Plant Equipment
531600
Annuals > 2 > balance Sheet > total Assets
12911582
Annuals > 2 > balance Sheet > payables
1150873
Annuals > 2 > balance Sheet > short Term Debt
139547
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2168664
Annuals > 2 > balance Sheet > equity
10718416
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2237262
Annuals > 2 > cash Flow > depreciation
687440
Annuals > 2 > cash Flow > change In Working Capital
-64320
Annuals > 2 > cash Flow > cash From Operations
-683095
Annuals > 2 > cash Flow > capital Expenditures
1054191
Annuals > 2 > cash Flow > cash From Investing
-1054191
Annuals > 2 > cash Flow > cash From Financing
-150347
Annuals > 2 > cash Flow > net Change In Cash
-1834897
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.005879031458668529
Annuals > 2 > ratios > PB
1.2426490658694347
Annuals > 2 > ratios > ROE
-20.87306557237562
Annuals > 2 > ratios > ROA
-17.32755908609805
Annuals > 2 > ratios > FCF
-1737286
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.950806465295257
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1228580
Annuals > 3 > income Statement > cost Of Revenue
1200260
Annuals > 3 > income Statement > gross Profit
28320
Annuals > 3 > income Statement > operating Expenses
3236600
Annuals > 3 > income Statement > operating Income
-3208280
Annuals > 3 > income Statement > interest Expense
32074
Annuals > 3 > income Statement > pretax Income
-3337503
Annuals > 3 > income Statement > net Income
-2788973
Annuals > 3 > income Statement > eps
-0.007332837252932295
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
380340229
Annuals > 3 > income Statement > income Tax Expense
-618137
Annuals > 3 > income Statement > EBITDA
-2715461
Annuals > 3 > income Statement > operating Margin
-261.13724787966595
Annuals > 3 > income Statement > total Other Income Expense Net
-187400
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
3829369
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
759905
Annuals > 3 > balance Sheet > inventories
521351
Annuals > 3 > balance Sheet > total Current Assets
6140552
Annuals > 3 > balance Sheet > property Plant Equipment
605065
Annuals > 3 > balance Sheet > total Assets
15027085
Annuals > 3 > balance Sheet > payables
1147823
Annuals > 3 > balance Sheet > short Term Debt
99924
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2197610
Annuals > 3 > balance Sheet > equity
12798356
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2788973
Annuals > 3 > cash Flow > depreciation
589971
Annuals > 3 > cash Flow > change In Working Capital
376147
Annuals > 3 > cash Flow > cash From Operations
-1618558
Annuals > 3 > cash Flow > capital Expenditures
1726196
Annuals > 3 > cash Flow > cash From Investing
-1726196
Annuals > 3 > cash Flow > cash From Financing
-90387
Annuals > 3 > cash Flow > net Change In Cash
-3457134
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.007332837252932295
Annuals > 3 > ratios > PB
1.0401264049070054
Annuals > 3 > ratios > ROE
-21.791650427601795
Annuals > 3 > ratios > ROA
-18.559640808579974
Annuals > 3 > ratios > FCF
-3344754
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.722455192173078
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.0034999159458368213
Valuation > metrics > PB
1.7651374606498826
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-17.650950700349824
Profitability > metrics > ROA
-35.728156640572664
Profitability > metrics > Net Margin
-1.5574755847764146
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.26977784274930944
Risk > metrics > Interest Coverage
-205.29563028232332
Risk > final Score
-761
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.592281850057778
Liquidity > metrics > Quick Ratio
2.2684458266331196
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
27
Prev Risks > 1
-819
Prev Risks > 2
-287
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:45:14.472Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-02
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products comprising companion animal, bio-control, parasite treatments, and insect sprays. Eden Research plc was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AEden Research shares rise as Mevalone gets French grape approval Proactive financial news
Read more →Eden Research edges higher after Italy renews approval for Ecovelex seed treatment Proactive financial news
Read more →(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Eden Research plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.